DISQVER® for Sepsis & Bloodstream Infections

About Noscendo

Noscendo is a privately held, commercial-stage diagnostics company based in Mannheim, Germany, founded in 2017. It has developed and launched DISQVER®, a proprietary AI-driven platform that analyzes cell-free DNA from blood samples using next-generation sequencing to detect a broad range of bacterial, viral, fungal, and parasitic pathogens. The company targets the critical unmet need for rapid, unbiased pathogen identification in sepsis and other complex infections, positioning itself at the intersection of advanced genomics, bioinformatics, and clinical diagnostics. Noscendo operates a B2B model, providing its testing service to hospitals and laboratories, and has established key partnerships to drive adoption and reimbursement.

Therapeutic Areas